rtpcresim
previous
demonstr
capabl
detect
identifi
respiratori
viral
pathogen
nasopharyng
swab
studi
expand
previou
research
perform
prospect
evalu
rtpcresim
detect
identifi
influenza
b
virus
compar
prodess
proflu
plu
combin
proflu
plu
cepheid
xpert
flu
proflu
plu
also
use
gold
standard
comparison
respiratori
syncyti
viru
detect
use
proflu
plu
gold
standard
rtpcresim
sensit
specif
respect
influenza
respect
influenza
b
influenza
viru
use
match
result
proflu
plu
xpert
flu
gold
standard
rtpcresim
sensit
specif
respect
influenza
respect
influenza
b
viru
overal
rtpcresim
sensit
combin
gold
standard
proflu
plu
xpert
flu
although
capabl
detect
respiratori
virus
influenza
virus
repres
season
signific
sourc
vari
morbid
mortal
base
strain
viru
circul
worldwid
popul
thompson
et
al
mahoni
mahoni
et
al
influenza
along
rhinovirusenteroviru
frequent
detect
respiratori
viru
outpati
visit
peopl
influenza
like
ill
fowlk
et
al
diagnost
assay
particularli
molecular
diagnost
assay
use
appli
influenza
viru
surveil
assist
diseas
manag
aid
clinic
decis
make
use
pathogen
discoveri
mahoni
mahoni
et
al
swayn
spackman
rtpcresim
complex
diagnost
technolog
evalu
influenza
viru
detect
genotyp
paninfluenza
detect
kit
jeng
et
al
murillo
et
al
tang
et
al
briefli
revers
transcript
pcr
electrospray
ioniz
mass
spectrometri
rtpcresim
commerci
develop
ibi
bioscienc
san
diego
ca
unit
state
technolog
analyz
pcr
product
via
mass
spectrometri
produc
accur
base
pair
composit
gener
pcr
product
base
pair
composit
pcr
product
plot
three
dimension
space
compar
databas
known
organ
organ
identif
made
base
align
base
pair
composit
pcr
product
base
pair
composit
known
organ
base
abil
technolog
detect
identifi
virus
bacteria
fungi
one
platform
potenti
flexibl
use
approach
detect
identifi
pathogen
clinic
sampl
addit
evalu
perform
broad
respiratori
viru
primer
rtpcresim
via
respiratori
viru
surveil
rv
kit
ibi
bioscienc
san
diego
ca
unit
state
detect
influenza
b
virus
respiratori
syncyti
viru
coronavirus
adenovirus
metapneumoviru
parainfluenza
viru
variou
gold
standard
assay
chen
et
al
b
forman
et
al
hardick
et
al
studi
sought
expand
previou
studi
comparison
rv
kit
two
molecular
diagnost
method
prodess
proflu
plu
hologicgen
probe
san
diego
ca
unit
state
cepheid
xpert
flu
cepheid
incorpor
sunnyval
ca
unit
state
determin
sensit
specif
kappa
statist
specif
influenza
b
virus
prospect
collect
nasopharyng
swab
adult
popul
novemb
march
part
ongo
irbapprov
studi
duga
et
al
examin
impact
xpert
flu
clinic
decis
make
popul
age
rang
median
age
met
center
diseas
control
prevent
criteria
antivir
therapi
emerg
medicin
depart
nasopharyng
swab
n
microtest
remel
lenexa
ks
unit
state
obtain
xpert
flu
evalu
confirmatori
test
prodess
proflu
plu
xpert
flu
prodess
proflu
plu
perform
per
manufactur
instruct
use
sampl
per
test
respect
multipl
aliquot
nasopharyng
swab
one
xpert
flu
test
one
proflu
plu
test
one
rtpcresim
test
made
volum
store
prior
test
rtpcresim
ibi
biosciencesabbott
molecular
san
diego
ca
de
plain
il
unit
state
nucleic
acid
extract
perform
thaw
aliquot
use
arrow
viral
na
kit
diasorin
stillwat
mn
unit
state
per
manufactur
instruct
extract
amplifi
analyz
rv
kit
via
rtpcresim
posit
control
reaction
nattrol
respiratori
valid
panel
zeptometrix
corpor
buffalo
ny
unit
state
includ
extract
amplif
run
posit
reaction
defin
reaction
q
score
q
score
measur
confid
identifi
posit
xpert
flu
proflu
plu
result
avail
oper
rtpcr
esim
test
complet
rtpcresim
test
perform
john
hopkin
univers
irbapprov
studi
rv
kit
result
first
compar
proflu
plu
gold
standard
follow
combin
xpert
flu
proflu
plu
gold
standard
combin
xpert
flu
proflu
plu
result
posit
neg
reaction
defin
reaction
agreement
assay
test
data
use
calcul
sensit
specif
kappa
analysi
rv
kit
compar
gold
standard
influenza
viru
proflu
plu
use
gold
standard
sensit
specif
kappa
ci
respect
influenza
b
sensit
specif
kappa
ci
respect
rtpcresim
detect
addit
respiratori
virus
studi
patient
detect
comparison
assay
proflu
plu
detect
influenza
b
rsv
xpert
flu
exclus
influenza
ab
assay
rtpcresim
provid
basic
genotyp
inform
influenza
influenza
b
subtyp
detect
influenza
subtyp
influenza
b
primarili
yamagata
addit
inform
could
use
prospect
surveil
studi
technolog
discoveri
potenti
influenza
influenza
b
variant
genotyp
within
risk
popul
could
use
earli
detect
potenti
pandem
strain
influenza
well
gather
epidemiolog
data
regard
composit
influenza
b
subtyp
respiratori
season
result
similar
previou
rtpcresim
studi
although
comparison
method
studi
differ
chen
et
al
b
forman
et
al
hardick
et
al
studi
primarili
evalu
influenza
detect
capabl
rv
previou
evalu
compar
convent
viral
cultur
method
direct
fluoresc
antibodi
dfa
chen
et
al
b
xtag
rvp
dfa
xtag
rvp
alon
forman
et
al
addit
previou
studi
use
archiv
nasopharyng
swab
chen
et
al
b
hardick
et
al
prospect
pediatr
sampl
forman
et
al
studi
analyz
prospect
nasopharyng
swab
exclus
adult
emerg
depart
patient
compar
rtpcresim
perform
two
molecular
diagnost
method
limit
studi
notabl
rel
low
number
influenza
n
influenza
b
n
posit
sampl
howev
limit
resourc
prevent
enrol
requir
conclud
primari
studi
complet
duga
et
al
also
limit
perform
confirmatori
test
sampl
test
posit
respiratori
virus
influenza
influenza
b
rsv
howev
previous
mention
studi
examin
perform
rtpcresim
detect
identifi
respiratori
virus
indic
suffici
sensit
specif
technolog
detect
coronaviru
metapneumoviru
adenoviru
parainfluenza
chen
et
al
b
forman
et
al
hardick
et
al
rtpcresim
highli
complex
technolog
although
suit
toward
point
care
diagnost
test
multiplex
detect
capabl
similar
method
xtag
rvp
provid
basic
genotyp
inform
respiratori
virus
genotyp
inform
help
surveil
epidemiolog
respiratori
virus
particularli
influenza
b
outbreak
control
recognit
possibl
new
strain
substanti
evalu
rtpcresim
technolog
use
rv
kit
requir
technolog
directli
appli
clinic
use
evalu
present
illustr
rtpcresim
use
diagnost
method
detect
identif
influenza
influenza
b
virus
lower
sensit
studi
could
explain
differ
limit
detect
assay
proflu
plu
xpert
flu
report
limit
detect
low
pfuml
rtpcr
esim
report
limit
detect
approxim
copi
target
per
well
chen
et
al
b
